Ambion will now be distributing Agencourt’s AMPure reagent, which is based on its proprietary Solid Phase Reversible Immobilization nucleic acid reagents, along with its MessageAmp RNA amplification kit, the companies said this week. The SPRI chemistry, which is patented, is based on the use of magnetic microparticles, onto which nucleic acids are selectively immobilized.
Ambion, Agencourt
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.